阶段(地层学)
卵巢
医学
病态的
卵巢癌
疾病
肿瘤科
卵巢癌
粘液癌
癌症
化疗
内科学
病理
腺癌
生物
古生物学
作者
Abdulaziz Babaier,Prafull Ghatage
出处
期刊:Diagnostics
[MDPI AG]
日期:2020-01-19
卷期号:10 (1): 52-52
被引量:62
标识
DOI:10.3390/diagnostics10010052
摘要
Mucinous ovarian cancer (MOC) is a rare subtype of epithelial ovarian carcinoma (EOC). Whereas all EOC subtypes are addressed in the same way, MOC is a distinct entity. Appreciating the pathological features and genomic profile of MOC may result in the improvement in management and, hence, the prognosis. Distinguishing primary MOC from metastatic mucinous carcinoma can be challenging but is essential. Early-stage MOC carries an excellent prognosis, with advanced disease having a poor outcome. Surgical management plays an essential role in the early stage and in metastatic disease. Chemotherapy is usually administered for stage II MOC and beyond. The standard gynecology protocol is frequently used, but gastrointestinal regimens have also been administered. As MOC is associated with multiple molecular alterations, targeted therapy could be the answer to treat this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI